Supernus Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 9,861 | 0.0% | 198,406 | 12/31/2025 |
| 2025 Q3 | 11/6/2025 | 10,451 | 0.0% | 218,684 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 6,944 | 0.0% | 220,304 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 7,196 | 0.0% | 219,731 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 4,974 | 0.0% | 137,564 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 3,646 | 0.0% | 116,949 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 3,235 | 0.0% | 120,949 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 3,820 | 0.0% | 111,982 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 3,281 | 0.0% | 113,372 | 12/31/2023 |
| 2023 Q3 | 11/22/2023 | 1,860 | 0.0% | 67,477 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 2,907 | 0.0% | 96,696 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 3,445 | 0.0% | 95,075 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 3,498 | 0.0% | 98,057 | 12/31/2022 |
| 2022 Q3 | 1/10/2023 | 3,319 | 0.0% | 98,057 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 2,859 | 0.0% | 98,875 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 3,208 | 0.0% | 99,256 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 3,159 | 0.0% | 108,346 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 2,890 | 0.0% | 108,346 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 3,336 | 0.0% | 108,346 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 3,449 | 0.0% | 131,749 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,766 | 0.0% | 149,687 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 2,822 | 0.0% | 135,391 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 2,791 | 0.0% | 117,496 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 2,114 | 0.0% | 117,496 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 2,787 | 0.0% | 117,496 | 12/31/2019 |